London · Delayed Price · Currency is GBP · Price in GBX Faron Pharmaceuticals Oy Statistics
Total Valuation
AIM:FARN has a market cap or net worth of GBP 67.15 million. The enterprise value is 77.94 million.
| Market Cap | 67.15M |
| Enterprise Value | 77.94M |
Important Dates
The last earnings date was Wednesday, March 4, 2026.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:FARN has 115.78 million shares outstanding. The number of shares has increased by 28.30% in one year.
| Current Share Class | 115.78M |
| Shares Outstanding | 115.78M |
| Shares Change (YoY) | +28.30% |
| Shares Change (QoQ) | +0.77% |
| Owned by Insiders (%) | 21.10% |
| Owned by Institutions (%) | 6.46% |
| Float | 84.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 58.85 |
| PB Ratio | -4.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.28 |
| EV / Sales | 68.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.84
| Current Ratio | 0.84 |
| Quick Ratio | 0.65 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.93 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -79.81% |
| Return on Invested Capital (ROIC) | -278.02% |
| Return on Capital Employed (ROCE) | 1,113.92% |
| Weighted Average Cost of Capital (WACC) | 16.48% |
| Revenue Per Employee | 35,658 |
| Profits Per Employee | -743,071 |
| Employee Count | 32 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AIM:FARN has paid 1,745 in taxes.
| Income Tax | 1,745 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.86% in the last 52 weeks. The beta is 1.35, so AIM:FARN's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | -66.86% |
| 50-Day Moving Average | 134.29 |
| 200-Day Moving Average | 182.30 |
| Relative Strength Index (RSI) | 27.93 |
| Average Volume (20 Days) | 344,481 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:FARN had revenue of GBP 1.14 million and -23.78 million in losses. Loss per share was -0.21.
| Revenue | 1.14M |
| Gross Profit | 1.14M |
| Operating Income | -16.54M |
| Pretax Income | -23.78M |
| Net Income | -23.78M |
| EBITDA | -16.25M |
| EBIT | -16.54M |
| Loss Per Share | -0.21 |
Balance Sheet
The company has 10.75 million in cash and 21.53 million in debt, with a net cash position of -10.79 million or -0.09 per share.
| Cash & Cash Equivalents | 10.75M |
| Total Debt | 21.53M |
| Net Cash | -10.79M |
| Net Cash Per Share | -0.09 |
| Equity (Book Value) | -16.15M |
| Book Value Per Share | -0.13 |
| Working Capital | -2.66M |
Cash Flow
| Operating Cash Flow | -15.63M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,449.46% |
| Pretax Margin | -2,083.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AIM:FARN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.30% |
| Shareholder Yield | -28.30% |
| Earnings Yield | -35.41% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |